Mr. Reich leads transformative growth across Dana-Farber Cancer Institute’s clinical network. Under his leadership, Dana-Farber has expanded to include more than 20 hospital affiliations and forged strategic international partnerships, most recently extending the institute’s global footprint in the Middle East. He also spearheaded the launch of Dana-Farber’s international patient program, which now provides care to patients from more than 100 countries at its Boston campus. Mr. Reich was instrumental in shaping Dana-Farber’s groundbreaking clinical collaboration with Boston-based Beth Israel Deaconess Medical Center and Harvard Medical Faculty Physicians, an alliance that will support the Institute’s planned 300-bed inpatient hospital. Beyond institutional strategy, Mr. Reich has advanced initiatives that extend the institute’s reach and impact, including expanding need-based lodging programs and helping deliver Dana-Farber’s expertise to more than 1,000 community oncologists nationwide through the innovative “Pathways” program, a clinical decision support system that guides physicians through personalized, evidence-based treatment options.
